FDA Inspection
Centaur Pharmaceuticals Private Ltd.Centaur Pharmaceuticals Private Ltd. – FDA Inspection, Nov 14, 2016
Record Details
This FDA Inspection record concerns Centaur Pharmaceuticals Private Ltd., with an inspection on November 14, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7225abfc-7514-43fd-8130-95b98243d995
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1002848
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.111Establishment of time limitations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Centaur Pharmaceuticals Private Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 24, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| February 8, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Centaur Pharmaceuticals Private Ltd.
- FDA Inspection 1333532 - 2026-08-24
- FDA Inspection 1198364 - 2023-02-08
- FDA Inspection 1092125 - 2019-05-13
- FDA Inspection 871580 - 2014-03-27
- FDA Inspection 740704 - 2011-08-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.